Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey
Standard
Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey. / Wolf, Peter; Weger, Wolfgang; Legat, Franz; Painsi, Clemens; Saxinger, Werner; Müllegger, Robert; Sator, Paul; Ratzinger, Gudrun; Selhofer, Sylvia; Richter, Leo; Salmhofer, Wolfgang; Lange-Asschenfeldt, Bernhard; Trautinger, Franz; Mlynek, Alexander; Strohal, Robert; Augustin, Matthias; Quehenberger, Franz.
In: J DTSCH DERMATOL GES, Vol. 16, No. 8, 08.2018, p. 981-991.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey
AU - Wolf, Peter
AU - Weger, Wolfgang
AU - Legat, Franz
AU - Painsi, Clemens
AU - Saxinger, Werner
AU - Müllegger, Robert
AU - Sator, Paul
AU - Ratzinger, Gudrun
AU - Selhofer, Sylvia
AU - Richter, Leo
AU - Salmhofer, Wolfgang
AU - Lange-Asschenfeldt, Bernhard
AU - Trautinger, Franz
AU - Mlynek, Alexander
AU - Strohal, Robert
AU - Augustin, Matthias
AU - Quehenberger, Franz
N1 - © 2018 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
PY - 2018/8
Y1 - 2018/8
N2 - BACKGROUND: Patients with psoriasis experience impairment in quality of life. Thus, high-quality dermatological care is of particular importance.PATIENTS AND METHODS: We performed a nationwide cross-sectional survey in Austria (BQSAustria Psoriasis 2014/2015) with a special focus on quality of life and satisfaction with treatment among psoriasis patients predominantly treated at tertiary care centers.RESULTS: Overall, 70.2 % of 1,184 patients reported impaired quality of life (DLQI 2-5: 29.4 %; 6-10: 19.3 %; 11-15: 11.5 %; 16-20: 5.2 % and > 20: 4.9 %) despite treatment over the preceding four weeks (topical treatment in 88.2 % of cases and/or systemic treatment in 38.7 %). On average, none of the 25 defined subjective treatment goals was achieved to a sufficient degree. In particular, 82.2 % of patients continued to have pruritus despite treatment, which was highly significantly associated with a poor general health status over the preceding week (Spearman's rank correlation; p = 1.1e-45), the extent of body surface area (p = 3.2e-11) and scalp area (p = 3.2e-11) affected, as well as pain (p = 2.3e-22). Treatment with a biologic was significantly correlated with higher patient satisfaction (Wilcoxon-Test, p = 2.0e-16).CONCLUSIONS: Despite dermatological care, the majority of Austrian psoriasis patients continues to experience impaired quality of life; there is potential for improvement in the achievement of treatment goals.
AB - BACKGROUND: Patients with psoriasis experience impairment in quality of life. Thus, high-quality dermatological care is of particular importance.PATIENTS AND METHODS: We performed a nationwide cross-sectional survey in Austria (BQSAustria Psoriasis 2014/2015) with a special focus on quality of life and satisfaction with treatment among psoriasis patients predominantly treated at tertiary care centers.RESULTS: Overall, 70.2 % of 1,184 patients reported impaired quality of life (DLQI 2-5: 29.4 %; 6-10: 19.3 %; 11-15: 11.5 %; 16-20: 5.2 % and > 20: 4.9 %) despite treatment over the preceding four weeks (topical treatment in 88.2 % of cases and/or systemic treatment in 38.7 %). On average, none of the 25 defined subjective treatment goals was achieved to a sufficient degree. In particular, 82.2 % of patients continued to have pruritus despite treatment, which was highly significantly associated with a poor general health status over the preceding week (Spearman's rank correlation; p = 1.1e-45), the extent of body surface area (p = 3.2e-11) and scalp area (p = 3.2e-11) affected, as well as pain (p = 2.3e-22). Treatment with a biologic was significantly correlated with higher patient satisfaction (Wilcoxon-Test, p = 2.0e-16).CONCLUSIONS: Despite dermatological care, the majority of Austrian psoriasis patients continues to experience impaired quality of life; there is potential for improvement in the achievement of treatment goals.
KW - Journal Article
U2 - 10.1111/ddg.13613
DO - 10.1111/ddg.13613
M3 - SCORING: Journal article
C2 - 30117711
VL - 16
SP - 981
EP - 991
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
IS - 8
ER -